Target intelligence / Profile preview

Hyaluronic acid-dependent extracellular matrix scaffolding

Molecular classification
Other (biomaterial/extracellular matrix component, not a protein, enzyme, or receptor)
01

Overview

Hyaluronic acid-dependent extracellular matrix scaffolding refers to the process and structural phenomenon where hyaluronic acid (HA), a major natural glycosaminoglycan of the extracellular matrix, forms the backbone or primary component of biomaterial scaffolds used in tissue engineering and regenerative medicine. These scaffolds can be created as hydrogels, sponges, or fibrous matrices and are often designed to mimic the natural ECM environment, supporting cell adhesion, migration, and 3D tissue architecture. HA interacts with cell receptors (notably CD44) to regulate cellular processes such as proliferation, differentiation, and stemness, and these scaffolds are widely used in research and clinical applications for wound healing, cartilage regeneration, and as cancer models in vitro. As a "target," the term is imprecise: it represents an engineered or biological structure/material rather than a discrete molecular entity typically targeted by drugs.

Other names
Hyaluronic acid scaffoldHyaluronic acid-based extracellular matrixHA-based scaffoldHA-ECM scaffold
02

Mechanism of action

Provides a physical 3D environment conducive to cell survival, differentiation, and tissue formation. Interacts with cell surface receptors such as CD44, triggering downstream pathways that regulate adhesion, migration, and proliferation. Serves as a reservoir for growth factors and cytokines within the ECM. Supports cell-matrix signaling critical for tissue morphogenesis and regeneration.

03

Biological functions

Extracellular matrix formationCell adhesionCell migrationRegulation of cell proliferationTissue repair and regenerationSupport of stemness in some contextsModulation of inflammationAngiogenesis (in wound healing)Promotion of three-dimensional tissue architecture
04

Disease associations

Cancer (scaffold may facilitate tumor spheroid growth or metastasis modeling)Wound healing and tissue regenerationCartilage and bone defects (tissue engineering)Other (biomaterial uses in tissue repair, regenerative medicine)
05

Safety considerations

Potential immune response to scaffold materials (rare with HA plus purified ECM but possible depending on source)Biodegradation rate may mismatch tissue regeneration needsPossible promotion of unwanted cell proliferation (e.g., in cancer models, HA may support tumor growth/metastasis)Scaffolds may require antibiotic or anti-inflammatory adjuncts to prevent infection or adverse host response in clinical useBatch-to-batch variability with source material
06

Interacting drugs

No classic "drugs" targeting this structure/process, but hyaluronic acid-based scaffolds are used as biomaterials in wound dressings, tissue engineering, or injectable gels.

2 more in the full profile.

07

Biomarkers

CD44 (cell-surface HA receptor; its upregulation is seen in cells interacting with HA scaffolds)E-cadherin, albumin (markers altered in response to HA scaffolding in some 3D tumor models)Tenascin C, CD31, αSMA (used in studies to monitor wound healing supported by ECM-HA sheets)

Beyond the preview

Go deeper on Hyaluronic acid-dependent extracellular matrix scaffolding.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluronic acid-dependent extracellular matrix scaffolding.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call